Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 2–2 | Cite as

Japan's PMDA investigation results for March 2019

News item
  • 54 Downloads

References

  1. 1.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Quetiapine fumarate. Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228666.pdf
  2. 2.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Preparations containing vonoprazan fumarate. Internet Document : [4 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228668.pdf
  3. 3.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Clozapine. Internet Document : [1 page], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228667.pdf
  4. 4.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Denosumab (genetical recombination) (120 mg product). Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228669.pdf
  5. 5.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Intravenous injection products containing sorbitol or fructose as excipient. Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228670.pdf

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations